Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.

Ther Adv Gastroenterol · 2022 · PMC8848093 · PMID 35186121

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

a numerical trendno p-value reported

The patient’s age of >40 years at baseline showed a numerical trend, but the data did not reach statistical significance (adjusted OR: 0.39, 95% CI: 0.14–1.10, p = 0.07; Table 3 and Supplementary Table 1 ).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.